Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

KRT8 antibody (CF®640R)

This Mouse Monoclonal antibody specifically detects KRT8 in WB, IHC, IF and IHC (fp). It exhibits reactivity toward Human, Cow, Rabbit, Pig and Sheep.
Catalog No. ABIN7656253

Quick Overview for KRT8 antibody (CF®640R) (ABIN7656253)

Target

See all KRT8 Antibodies
KRT8 (Keratin 8 (KRT8))

Reactivity

  • 298
  • 84
  • 77
  • 66
  • 65
  • 63
  • 62
  • 16
  • 14
  • 10
  • 8
  • 5
  • 4
  • 3
  • 2
  • 1
  • 1
  • 1
Human, Cow, Rabbit, Pig, Sheep

Host

  • 155
  • 155
  • 3
Mouse

Clonality

  • 170
  • 140
  • 1
Monoclonal

Conjugate

  • 162
  • 26
  • 18
  • 9
  • 8
  • 7
  • 7
  • 7
  • 7
  • 7
  • 6
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This KRT8 antibody is conjugated to CF®640R

Application

  • 216
  • 151
  • 120
  • 90
  • 70
  • 42
  • 41
  • 41
  • 40
  • 34
  • 30
  • 28
  • 23
  • 5
  • 5
  • 4
  • 4
  • 2
  • 2
  • 2
  • 1
  • 1
Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (IF), Immunohistochemistry (Formalin-fixed Paraffin-embedded Sections) (IHC (fp))

Clone

B22-1
  • Purpose

    Cytokeratin 8 (KRT8)(B22.1), CF640R conjugate

    Characteristics

    Cytokeratin 8 (CK8) belongs to the type II (or B or basic) subfamily of high molecular weight cytokeratins and exists in combination with cytokeratin 18 (CK18). CK8 is primarily found in the non-squamous epithelia and is present in majority of adenocarcinomas and ductal carcinomas. It is absent in squamous cell carcinomas. Hepatocellular carcinomas are defined by the use of antibodies that recognize only cytokeratin 8 and 18. CK8 exists on several types of normal and neoplastic epithelia, including many ductal and glandular epithelia such as colon, stomach, small intestine, trachea, and esophagus as well as in transitional epithelium. Anti-CK8 does not react with skeletal muscle or nerve cells. Epithelioid sarcoma, chordoma, and adamantinoma show strong positivity corresponding to that of simple epithelia (with antibodies against CK8, CK18 and CK19). Reportedly, anti-CK8 is useful for the differentiation of lobular ('ring-like, perinuclear') from ductal ('peripheral-predominant') carcinoma of the breast. Primary antibodies are available purified, or with a selection of fluorescent CF® Dyes and other labels. CF® Dyes offer exceptional brightness and photostability. Note: Conjugates of blue fluorescent dyes like CF®405S and CF®405M are not recommended for detecting low abundance targets, because blue dyes have lower fluorescence and can give higher non-specific background than other dye colors.

    Immunogen

    Cytoskeletal preparation from HeLa cells

    Isotype

    IgG1, kappa
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Comment

    Positive Control: MCF-7 or A431 cells. Skin, Colon, lung or breast carcinoma

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    0.1 mg/mL

    Buffer

    PBS, 0.1 % BSA, 0.05 % azide

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Handling Advice

    Protect from light

    Storage

    4 °C

    Storage Comment

    Stable at room temperature or 37°C for 7 days.

    Protect from light

    Store at 2 to 8°C. Protect fluorescent conjugates from light

    Expiry Date

    24 months
  • Target

    KRT8 (Keratin 8 (KRT8))

    Alternative Name

    Keratin 8

    Background

    Synonyms: CARD2, CK8, CYK8, CYKER, Cytokeratin Endo A, DreK8, EndoA, K2C8, K8, Keratin 8, Krt 2.8, KRT8, Type-II Keratin Kb8

    Gene Symbol: KRT8

    Tissue Expression: Epithelial cells

    Molecular Weight

    52.5 kDa

    Gene ID

    3856

    UniProt

    P05787
You are here:
Chat with us!